Folkhälsan Institute of Genetics, Folkhälsan Research Center, 00290 Helsinki, Finland.
Department of Nephrology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.
Nutrients. 2021 Oct 30;13(11):3909. doi: 10.3390/nu13113909.
Although nut consumption has been associated with several health benefits, it has not been investigated in individuals with type 1 diabetes. Therefore, our aim was to assess nut consumption and its association with metabolic syndrome in adult individuals with type 1 diabetes taking part in the Finnish Diabetic Nephropathy Study. The nut intake of the 1058 participants was assessed from 3-day food records that were completed twice, and the number of weekly servings, assuming a serving size of 28.4 g, was calculated. Metabolic syndrome was defined as the presence of ≥3 of the cardiovascular risk factors: central obesity, high blood pressure (≥130/85 mmHg or use of antihypertensive medication), high triglyceride concentration (≥1.70 mmol/L or use of lipid-lowering medication), low HDL-cholesterol concentration (<1.00 mmol/L in men and <1.30 mmol/L in women or use of lipid-lowering medication), and hyperglycaemia. Overweight/obesity was defined as a BMI ≥25 kg/m. HbA > 59 mmol/mol (>7.5%) was used as a criterion for suboptimal glycaemic control. Of the 1058 (mean age 46 years, 41.6% men) participants, 689 (54.1%) reported no nut intake. In the remaining sample, the median weekly nut intake was 40.8 g. In the adjusted models, higher nut intake, as the continuous number of weekly servings and the comparison of those with <2 and ≥2 weekly servings, was associated with lower metabolic syndrome score, waist circumference, HbA, and BMI. Nut consumption as a continuous variable was negatively associated with the presence of metabolic syndrome, its blood pressure, triglyceride, and HDL-cholesterol components, and suboptimal glycaemic control. Consumption of ≥2 weekly servings was associated with lower odds of suboptimal glycaemic control (by 51.5%), overweight/obesity (by 33.4%), and metabolic syndrome (by 51.8%) and meeting the waist (by 37.3%), blood pressure (by 44.5%), triglyceride (by 37.7%), and HDL-cholesterol (by 36.2%) components of the metabolic syndrome. In conclusion, a weekly nut intake of ≥2 servings was beneficially associated with all the components of the metabolic syndrome in type 1 diabetes. The causality of this association will need to be investigated.
尽管坚果摄入与多种健康益处有关,但在 1 型糖尿病患者中尚未进行研究。因此,我们的目的是评估坚果的摄入量及其与参与芬兰糖尿病肾病研究的 1 型糖尿病成人代谢综合征的关系。1058 名参与者的坚果摄入量是根据两次完成的 3 天食物记录评估的,假设每份 28.4 克,计算每周的份数。代谢综合征的定义是存在≥3 个心血管危险因素:中心性肥胖、高血压(≥130/85mmHg 或使用抗高血压药物)、高甘油三酯浓度(≥1.70mmol/L 或使用降脂药物)、低高密度脂蛋白胆固醇浓度(男性<1.00mmol/L,女性<1.30mmol/L 或使用降脂药物)和高血糖。超重/肥胖定义为 BMI≥25kg/m。HbA>59mmol/mol(>7.5%)被用作血糖控制不理想的标准。在 1058 名(平均年龄 46 岁,41.6%为男性)参与者中,689 名(54.1%)报告没有坚果摄入。在其余样本中,每周坚果摄入量中位数为 40.8 克。在调整后的模型中,较高的坚果摄入量,作为每周食用份数的连续变量和每周食用<2 份和≥2 份的比较,与较低的代谢综合征评分、腰围、HbA 和 BMI 相关。作为连续变量的坚果摄入量与代谢综合征及其血压、甘油三酯和高密度脂蛋白胆固醇成分以及血糖控制不理想呈负相关。每周食用≥2 份与血糖控制不理想(降低 51.5%)、超重/肥胖(降低 33.4%)和代谢综合征(降低 51.8%)以及符合腰围(降低 37.3%)、血压(降低 44.5%)、甘油三酯(降低 37.7%)和高密度脂蛋白胆固醇(降低 36.2%)的代谢综合征成分的风险较低有关。总之,每周食用≥2 份坚果与 1 型糖尿病代谢综合征的所有成分均有益相关。这种关联的因果关系需要进一步研究。